Overview

Phase III Trial of Stage I Ovarian Cancer After Surgery

Status:
Recruiting
Trial end date:
2030-02-01
Target enrollment:
Participant gender:
Summary
To compare the Overall survival of adjuvant chemotherapy versus observation in stage I epithelial ovarian cancer after comprehensive staging surgery
Phase:
Phase 3
Details
Lead Sponsor:
Japanese Gynecologic Oncology Group
Collaborator:
Korean Gynecologic Oncology Group
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel